The rare bone condition known as Osteomalacia also occurred twice as often among GLP-1 users
If you are interested in learning about the specials we are running, check them out below
The drugs are used to treat type 2 diabetes and obesity
We can offer this as well, but pricing varies depending on your prescribed dosage
- Stay in regular communication with your doctor and attend follow-up appointments
Since control of diabetes and obesity are significant health outcome risk factors, it is conceivable that the shortages and high cost of GLP1 agonists will exacerbate existing health disparities. David Cutler, MD His perspective echoed what Ma told us, namely that [o]ne of the biggest bottlenecks with GLP-1RA access is cost and insurance. Even if a doctor prescribes [this type of drug], patients cannot obtain it if their insurance does not cover it, which could worsen disparities, especially for those with public insurance or in underserved populations, he also emphasized